Top Markets
#1 DogBull DogBull +105.79%
#2 ADO Protocol ADO Protocol +50.39%
#3 Siacoin Siacoin +46.43%
#4 MarsCoin MarsCoin +38.80%
#5 The Bitcoin Bull The Bitcoin Bull +37.59%
#6 Glidr Glidr +24.49%
#7 Ontology Gas Ontology Gas +24.38%
#8 UnifAI Network UnifAI Network +21.47%
#9 Useless Coin Useless Coin +19.16%
#10 Falcon Finance Falcon Finance +17.48%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
Rank in Stocks #15776
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
Share Price
$7.54
Market Cap
$331.60M
Change (1 day)
-3.79%
Change (1 year)
-75.66%
Country
KR
Trade GemVax&KAEL Co.,Ltd (082270)

Category

Industrials
Revenue for GemVax&KAEL Co.,Ltd (082270)
Revenue in Sep 2026 TTM: 0
According to GemVax&KAEL Co.,Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GemVax&KAEL Co.,Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Lam Research Corp. R Lam Research Corp. R
Lam Research Corp. R
LAR0.DE
 - -
US
Siemens AG Siemens AG
Siemens AG
SIE.DE
 $96.21B -
DE
Schneider Electric S.E. Schneider Electric S.E.
Schneider Electric S.E.
SU.PA
 - -
FR
Siemens Energy AG Siemens Energy AG
Siemens Energy AG
ENR.DE
 - -
DE
Parker-Hannifin Corporation Parker-Hannifin Corporation
Parker-Hannifin Corporation
PH.US
 $21.50B -
US